EN
RU
Diquafosol Tetrasodium (CAS: 211427-08-6) is a GMP-compliant, high-purity selective P2Y2 purinergic receptor agonist API. It promotes tear and mucin secretion to repair ocular surface damage, approved for dry eye disease treatment. It fully meets ICH, JP, USP and EP pharmacopoeial standards, ideal for ophthalmic eye drop formulation R&D and commercial manufacturing.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
211427-08-6
Product categoriesGlobalEquipX is a professional platform dedicated to the global pharmaceutical industry,
Backed by strong industry expertise, one of our co-founders serves as a strategic advisor to leading pharmaceutical manufacturers and R&D companies in China, including HEC and Menovo, giving us unique insight into market trends and client needs.
With numerous pharmaceutical manufacturers sites, we always ensure consistent quality and sustainable supply.
With over 30 years of proven experiences in import and export in EXP/IMP, we deliver flexible cooperation models and comprehensive one-stop solutions covering API & Intermediate, chemicals, and equipment—helping our clients streamline sourcing and accelerate business growth.
We do hope to have the chance to supply you our sustainable qualified service.
| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
Diquafosol Tetrasodium (CAS: 211427-08-6) is a GMP-compliant, high-purity selective P2Y2 purinergic receptor agonist API. It promotes tear and mucin secretion to repair ocular surface damage, approved for dry eye disease treatment. It fully meets ICH, JP, USP and EP pharmacopoeial standards, ideal for ophthalmic eye drop formulation R&D and commercial manufacturing.
Our hours
Public Account
IPv6 network supported
Technical Articles
